Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769729010 | Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3769730017 | Carmustine 7.7 mg prolonged-release intralesional implant | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4531361000052111 | karmustin 7,7 milligram/implantat, intralesionellt implantat med förlängd frisättning | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Has basis of strength substance (attribute) | Carmustine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | har nämnarvärde som visar styrka | ett | false | Inferred relationship | Some | 1 | |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Has manufactured dose form | Prolonged-release intralesional implant | true | Inferred relationship | Some | ||
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | räkning av bas i aktiv ingrediens | ett | false | Inferred relationship | Some | ||
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Has precise active ingredient | Carmustine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Has unit of presentation | Implant (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Has presentation strength denominator unit (attribute) | Implant (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | har täljarvärde som visar styrka | 7,7 | false | Inferred relationship | Some | 1 | |
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Is a | Product containing only carmustine in prolonged-release intralesional implant (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR